<DOC>
	<DOCNO>NCT01548209</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) common follow beast surgery . Dexmedetomidine report reduced PONV due opioid-sparing effect . It clear dexmedetomidine useful reduce PONV . The hypothesis present study : intraoperative application single dose dexmedetomidine ( 0.5 mcg/kg ) effective placebo reduce PONV improve postoperative quality recovery score within 48 postoperative hour .</brief_summary>
	<brief_title>Effects Dexmedetomidine Quality Recovery 40 Postoperative Nausea Vomiting Breast Cancer Surgery</brief_title>
	<detailed_description>This study approve Institutional Review Board Severance Hospital , Yonsei University Health System . After write informed consent obtain patient , age 20-75 year ASA physical status class I-II schedule breast cancer surgery general anaesthesia enrol study All patient randomly assign receive dexmedetomidine placebo surgery . The primary outcome quality recovery determine QOR-40 first 24h surgery.The secondary outcome measure PONV assess visual analogue scale every 6 hour within 48 postoperative hour .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA I , II age 2070 year Undergoing breast cancer surgery CAOD Bradycardia QT prolongation</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>